DE3875765D1 - - Google Patents

Info

Publication number
DE3875765D1
DE3875765D1 DE88104365T DE3875765T DE3875765D1 DE 3875765 D1 DE3875765 D1 DE 3875765D1 DE 88104365 T DE88104365 T DE 88104365T DE 3875765 T DE3875765 T DE 3875765T DE 3875765 D1 DE3875765 D1 DE 3875765D1
Authority
DE
Germany
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE88104365T
Other languages
German (de)
Other versions
DE3875765T2 (de
Inventor
Sumanas Dollard-Des-Ormeaux Quebec H9A 3A5 Ca Rakhit
Mahesh H. Laval Quebec H7N 5C7 Ca Goghari
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bio Mega Boehringer Ingelheim Research Inc
Original Assignee
Bio Mega Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bio Mega Inc filed Critical Bio Mega Inc
Application granted granted Critical
Publication of DE3875765D1 publication Critical patent/DE3875765D1/de
Publication of DE3875765T2 publication Critical patent/DE3875765T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/58—Atrial natriuretic factor complex; Atriopeptin; Atrial natriuretic peptide [ANP]; Cardionatrin; Cardiodilatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Cardiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Molecular Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Endocrinology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biophysics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
DE8888104365T 1987-03-25 1988-03-18 Fluor enthaltende atriale natriuretische peptide. Expired - Fee Related DE3875765T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CA532982 1987-03-25
CA542192 1987-07-15

Publications (2)

Publication Number Publication Date
DE3875765D1 true DE3875765D1 (sv) 1992-12-17
DE3875765T2 DE3875765T2 (de) 1993-03-25

Family

ID=25671281

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8888104365T Expired - Fee Related DE3875765T2 (de) 1987-03-25 1988-03-18 Fluor enthaltende atriale natriuretische peptide.

Country Status (7)

Country Link
US (1) US5095004A (sv)
EP (1) EP0283956B1 (sv)
JP (1) JPS646296A (sv)
AU (1) AU605259B2 (sv)
DE (1) DE3875765T2 (sv)
IL (1) IL85728A (sv)
NZ (1) NZ223885A (sv)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5376635A (en) * 1987-03-15 1994-12-27 Bio-Mega/Boehringer Ingelheim Research Inc. Fluorine containing atrial natriuretic peptides
JP2539940Y2 (ja) * 1993-03-23 1997-07-02 村田機械株式会社 ブレイダー
US5665704A (en) * 1993-11-12 1997-09-09 Genentech, Inc. Receptor specific atrial natriuretic peptides
US6525022B1 (en) 1993-11-12 2003-02-25 Genentech, Inc. Receptor specific atrial natriuretic peptides
US5846932A (en) * 1993-11-12 1998-12-08 Genentech, Inc. Receptor specific atrial natriuretic peptides
CA2342471C (en) * 1995-06-06 2002-10-29 Judith L. Treadway Heterocyclecarbonylmethyl amine intermediates
AR004980A1 (es) * 1995-11-29 1999-04-07 Nihon Nohyaku Co Ltd Fungicida para la fruta de cultivo, derivado de fenilalanina comprendido como ingrediente activo en el mismo y metodo para controlar enfermedades enplantas aplicando dicho fungicida.
US6277877B1 (en) 2000-08-15 2001-08-21 Pfizer, Inc. Substituted n-(indole-2-carbonyl)glycinamides and derivates as glycogen phosphorylase inhibitors
US7795221B2 (en) * 2006-03-30 2010-09-14 Palatin Technologies, Inc. Linear natriuretic peptide constructs
US8580746B2 (en) * 2006-03-30 2013-11-12 Palatin Technologies, Inc. Amide linkage cyclic natriuretic peptide constructs
WO2007115175A2 (en) 2006-03-30 2007-10-11 Palatin Technologies, Inc. Cyclic natriuretic peptide constructs

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0180615B1 (en) * 1984-04-19 1995-04-05 Scios Nova Inc. Novel atrial natriuretic/vasodilator polypeptides
AU4292785A (en) * 1984-04-24 1985-11-15 Salk Institute For Biological Studies, The Atrial peptide analogs
JPS61233698A (ja) * 1985-04-09 1986-10-17 Ajinomoto Co Inc 新規ペプチド
JPH0672157B2 (ja) * 1984-08-29 1994-09-14 味の素株式会社 新規ペプチド
DE3443257A1 (de) * 1984-11-28 1986-05-28 Bissendorf Peptide GmbH, 3002 Wedemark Mittel enthaltend vollsynthetisches alpha-humanes atriales natriuretisches peptid (alpha-hanap)
JPS61161299A (ja) * 1985-01-04 1986-07-21 メルク　エンド　カムパニ−　インコ−ポレ−テツド 心房ペプチド
US4652549A (en) * 1985-01-22 1987-03-24 Merck & Co., Inc. Cardiac anti-hypertrophic agents
JPS61243100A (ja) * 1985-04-19 1986-10-29 アボツト　ラボラトリ−ズ Ａｎｐ誘導体
EP0262942A1 (en) * 1986-09-30 1988-04-06 Smithkline Beecham Corporation Cell transfection
ATE67787T1 (de) * 1986-10-15 1991-10-15 Battelle Memorial Institute Verfahren zur herstellung von proteinen mittels induzierbarer expressionssysteme in in-vivovermehrten, genetisch modifizierten eukaryotischen wirtszellen.

Also Published As

Publication number Publication date
NZ223885A (en) 1989-10-27
DE3875765T2 (de) 1993-03-25
JPS646296A (en) 1989-01-10
IL85728A0 (en) 1988-08-31
AU605259B2 (en) 1991-01-10
EP0283956A2 (en) 1988-09-28
US5095004A (en) 1992-03-10
EP0283956B1 (en) 1992-11-11
AU1316788A (en) 1988-11-24
EP0283956A3 (en) 1990-04-11
IL85728A (en) 1993-01-14

Similar Documents

Publication Publication Date Title
DE3882840D1 (sv)
GR3005666T3 (sv)
DE3882958D1 (sv)
DE3866070D1 (sv)
GR3003849T3 (sv)
GR3003857T3 (sv)
IN171134B (sv)
FR2618223B1 (sv)
GR3004854T3 (sv)
GR3003595T3 (sv)
IN170859B (sv)
IN171716B (sv)
IN171907B (sv)
DE3875765D1 (sv)
FR2619879B1 (sv)
IN171796B (sv)
FR2622843B1 (sv)
FR2613442B1 (sv)
GR3003935T3 (sv)
FR2624160B1 (sv)
HU201151B (sv)
DE3870578D1 (sv)
GR3003900T3 (sv)
GB8807925D0 (sv)
ATA244887A (sv)

Legal Events

Date Code Title Description
8327 Change in the person/name/address of the patent owner

Owner name: BIO-MEGA/BOEHRINGER INGELHEIM RESEARCH INC., LAVAL

8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee